GB2587755A - A method and apparatus for user-controlled or practitioner-prescribed transdermal, intradermal or transappendageal delivery of therapeutic, cosmetic or skin - Google Patents

A method and apparatus for user-controlled or practitioner-prescribed transdermal, intradermal or transappendageal delivery of therapeutic, cosmetic or skin Download PDF

Info

Publication number
GB2587755A
GB2587755A GB2100486.6A GB202100486A GB2587755A GB 2587755 A GB2587755 A GB 2587755A GB 202100486 A GB202100486 A GB 202100486A GB 2587755 A GB2587755 A GB 2587755A
Authority
GB
United Kingdom
Prior art keywords
user
practitioner
variable
prescribed
electromagnetophoretic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB2100486.6A
Other versions
GB202100486D0 (en
GB2587755A8 (en
Inventor
D Edwards Jeffrey
Mcildowie Matthew
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
International Scient Pty Ltd
International Scientific Pty Ltd
Original Assignee
International Scient Pty Ltd
International Scientific Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2018902547A external-priority patent/AU2018902547A0/en
Application filed by International Scient Pty Ltd, International Scientific Pty Ltd filed Critical International Scient Pty Ltd
Publication of GB202100486D0 publication Critical patent/GB202100486D0/en
Publication of GB2587755A publication Critical patent/GB2587755A/en
Publication of GB2587755A8 publication Critical patent/GB2587755A8/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N2/00—Magnetotherapy
    • A61N2/002—Magnetotherapy in combination with another treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/20—Applying electric currents by contact electrodes continuous direct currents
    • A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/325—Applying electric currents by contact electrodes alternating or intermittent currents for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/40—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N2/00—Magnetotherapy
    • A61N2/02—Magnetotherapy using magnetic fields produced by coils, including single turn loops or electromagnets
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M2037/0007—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin having means for enhancing the permeation of substances through the epidermis, e.g. using suction or depression, electric or magnetic fields, sound waves or chemical agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/50—General characteristics of the apparatus with microprocessors or computers

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medical Informatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Primary Health Care (AREA)
  • Dermatology (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Electrotherapy Devices (AREA)
  • Medicinal Preparation (AREA)

Abstract

A method and apparatus for the user-controlled or practitioner-prescribed transdermal, intradermal or transappendageal delivery of therapeutic, cosmetic or skin care ingredients of a quality, or at a rate, depth, intensity, dosage or concentration, selected or specified by the user or practitioner, effected by an interactive user or practitioner programmable electromagnetophoretic delivery device receiving at least one variable user-defined or practitioner-prescribed outcome selected or specified by the user or practitioner.

Claims (27)

CLAIMS:
1. A method for user-controlled or practitioner-prescribed transdermal, intradermal or transappendageal delivery of therapeutic, cosmetic or skin care ingredients, comprising; a) inputting at least one variable, user-defined or practitioner-prescribed outcome selected or specified by the user or practitioner into a system adapted for programming an interactive user or practitioner programmable electromagnetophoretic delivery device; b) optionally, receiving one or more additional variable parameters regarding the user- controlled or practitioner-prescribed transdermal, intradermal or transappendageal delivery method; c) executing an algorithm to derive at least one control instruction for the electromagnetophoretic delivery device utilising the at least one variable user- defined or practitioner-prescribed outcome, and where received, the one or more variable additional parameters; and d) providing the at least one control instruction to the electromagnetophoretic delivery device to effect the user-controlled or practitioner-prescribed transdermal, intradermal or transappendageal delivery of therapeutic, cosmetic or skin care ingredients of a quality, or at a rate, depth, dosage, intensity or concentration, selected or specified by the user or practitioner.
2. The method of claim 1 wherein the one or more additional variable parameters is a variable user, patient or subject parameter.
3. The method of any one of the preceding claims, wherein the one or more additional variable parameters is a variable environmental parameter.
4. The method of any one of the preceding claims, wherein the one or more additional variable parameters is a variable therapeutic, cosmetic or skin care composition parameter.
5. The method of any one of the preceding claims, wherein the one or more additional variable parameters is a variable environmental parameter that is at least one of an ambient temperature value, an ambient atmospheric pressure value, and an ambient humidity value.
6. The method of any one of the preceding claims, wherein the one or more additional variable parameters is a variable therapeutic, cosmetic or skin care composition parameter that is a characteristic of the therapeutic, cosmetic or skin care composition or of the substance or active constituent of the therapeutic, cosmetic or skin care composition to be delivered by the electromagnetophoretic delivery device.
7. The method of any one of the preceding claims, wherein the one or more additional variable parameters is a variable user, patient or subject parameter that is a characteristic of the dermal layer to which the electromagnetophoretic delivery device is to be applied.
8. The method of any one of the preceding claims, wherein the one or more additional variable parameters is a variable environmental parameter that is a geographical location of the user, patient or subject.
9. The method of any one of the preceding claims, wherein the one or more additional variable parameters is a variable user, patient or subject parameter that is an ethnicity of the user, patient or subject.
10. The method of any one of the preceding claims, wherein the one or more additional variable parameters is a variable user, patient or subject parameter that is an age group of the user, patient or subject.
11. The method of any one of the preceding claims, wherein the one or more additional variable parameters is a therapeutic, cosmetic or skin care composition parameter that is the identity of the therapeutic, cosmetic or skin care composition to be delivered by the electromagnetophoretic delivery device.
12. The method of any one of the preceding claims, wherein the at least one variable user- defined or practitioner-prescribed outcome is the choice of a specific quality of a multifunctional therapeutic, cosmetic or skin care composition to be delivered by the electromagnetophoretic delivery device.
13. The method of any one of the preceding claims, wherein the at least one variable user- defined or practitioner-prescribed outcome is the desired rate, depth, level of intensity, dosage or concentration, of delivery of the therapeutic, cosmetic or skin care composition to be delivered by the electromagnetophoretic delivery device.
14. The method of any one of the preceding claims, wherein the at least one control instruction is provided utilising a wireless communication device.
15. An interactive user or practitioner programmable electromagnetophoretic delivery device, adapted to perform the method of any one of the preceding claims.
16. The interactive user or practitioner programmable electromagnetophoretic delivery device of claim 15, comprising; a) an interface adapted to receive at least one variable user-defined or practitioner- prescribed outcome selected or specified by the user or practitioner; b) a data input module adapted to optionally receive one or more additional variable parameters regarding the user-controlled or practitioner-prescribed transdermal, intradermal or transappendageal delivery method; c) a processor adapted to execute an algorithm to derive at least one control instruction for the electromag netophoretic delivery device by processing the at least one variable user-defined or practitioner-prescribed outcome, and where received, the one or more variable additional parameters; and d) a delivery module adapted to utilise the at least one control instruction to effect the user-controlled or practitioner-prescribed transdermal, intradermal or transappendageal delivery method.
17. A system for programming the electromagnetophoretic delivery device of claim 15 or claim 16, comprising; a) an interface adapted to receive at least one variable user-defined or practitioner- prescribed outcome selected or specified by the user or practitioner; b) a data input module adapted to optionally receive one or more additional variable parameters regarding the user-controlled or practitioner-prescribed transdermal, intradermal or transappendageal delivery method; c) a processor adapted to execute an algorithm to derive at least one control instruction for the electromagnetophoretic delivery device by processing the at least one variable user-defined or practitioner-prescribed outcome, and where received, the one or more variable additional parameters; and d) an output module adapted to provide the at least one instruction to the electromagnetophoretic delivery device to effect the user-controlled or practitioner- prescribed transdermal, intradermal or transappendageal delivery method.
18. A computer program including at least one command, which, when executed on a computing system, is adapted to perform the method steps of any one of claims 1 to 14.
19. A computer readable medium incorporating a computer program in accordance with Claim 18
20. A data signal encoding at least one command and being adapted to be receivable by at least one computing system, wherein, when the encoded command is executed on the computing system, the computing system performs the method steps of at least one of Claims 1 to 14.
21. Use of the device of claim 15 or claim 16 to perform the method steps of at least one of Claims 1 to 14.
22. Use of the system of claim 17 to perform the method steps of at least one of Claims 1 to 14.
23. Use of the computer program of claim 18 to perform the method steps of at least one of Claims 1 to 14.
24. Use of the computer readable medium of claim 19 to perform the method steps of at least one of Claims 1 to 14.
25. Use of the data signal of claim 20 to perform the method steps of at least one of Claims 1 to 14.
26. A therapeutic, cosmetic or skin care composition for use in the method of at least one of claims 1 to 14.
27. A kit comprising the device of claim 15 or claim 16 and the composition of claim 26 for use in the method of at least one of claims 1 to 14.
GB2100486.6A 2018-07-13 2019-07-09 A method and apparatus for user-controlled or practitioner-prescribed transdermal, intradermal or transappendageal delivery of therapeutic, cosmetic or skin Withdrawn GB2587755A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2018902547A AU2018902547A0 (en) 2018-07-13 A Method and Apparatus for User-Controlled Transdermal, Intradermal or Transappendageal Delivery of Cosmetic or Skin Care Ingredients
AU2019901932A AU2019901932A0 (en) 2019-06-04 A Method and Apparatus for User-Controlled or Practitioner-Prescribed Transdermal, Intradermal or Transappendageal Delivery of Therapeutic, Cosmetic or Skin Care Ingredients
PCT/AU2019/050715 WO2020010388A1 (en) 2018-07-13 2019-07-09 A method and apparatus for user-controlled or practitioner-prescribed transdermal, intradermal or transappendageal delivery of therapeutic, cosmetic or skin care ingredients

Publications (3)

Publication Number Publication Date
GB202100486D0 GB202100486D0 (en) 2021-03-03
GB2587755A true GB2587755A (en) 2021-04-07
GB2587755A8 GB2587755A8 (en) 2021-05-19

Family

ID=69142206

Family Applications (1)

Application Number Title Priority Date Filing Date
GB2100486.6A Withdrawn GB2587755A (en) 2018-07-13 2019-07-09 A method and apparatus for user-controlled or practitioner-prescribed transdermal, intradermal or transappendageal delivery of therapeutic, cosmetic or skin

Country Status (3)

Country Link
AU (1) AU2019301569A1 (en)
GB (1) GB2587755A (en)
WO (1) WO2020010388A1 (en)

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5869326A (en) * 1996-09-09 1999-02-09 Genetronics, Inc. Electroporation employing user-configured pulsing scheme
US6009346A (en) * 1998-01-02 1999-12-28 Electromagnetic Bracing Systems, Inc. Automated transdermal drug delivery system
US6029090A (en) * 1997-01-27 2000-02-22 Herbst; Ewa Multi-functional electrical stimulation system
WO2007079189A2 (en) * 2005-12-30 2007-07-12 Tti Ellebeau, Inc. System and method for remote based control of an iontophoresis device
US20120191052A1 (en) * 2000-10-06 2012-07-26 Ip Holdings, Inc. Intelligent activated skin patch system
WO2013033782A1 (en) * 2011-09-09 2013-03-14 International Scientific Pty Ltd Method and device for transdermal delivery of substances
WO2014075136A1 (en) * 2012-11-14 2014-05-22 International Scientific Pty Ltd A device, system, method, computer program and data signal for the control of a transdermal delivery device
US20160220804A1 (en) * 2015-02-03 2016-08-04 L'oreal Apparatus and method for skin treatment using continuous light

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5869326A (en) * 1996-09-09 1999-02-09 Genetronics, Inc. Electroporation employing user-configured pulsing scheme
US6029090A (en) * 1997-01-27 2000-02-22 Herbst; Ewa Multi-functional electrical stimulation system
US6009346A (en) * 1998-01-02 1999-12-28 Electromagnetic Bracing Systems, Inc. Automated transdermal drug delivery system
US20120191052A1 (en) * 2000-10-06 2012-07-26 Ip Holdings, Inc. Intelligent activated skin patch system
WO2007079189A2 (en) * 2005-12-30 2007-07-12 Tti Ellebeau, Inc. System and method for remote based control of an iontophoresis device
WO2013033782A1 (en) * 2011-09-09 2013-03-14 International Scientific Pty Ltd Method and device for transdermal delivery of substances
WO2014075136A1 (en) * 2012-11-14 2014-05-22 International Scientific Pty Ltd A device, system, method, computer program and data signal for the control of a transdermal delivery device
US20160220804A1 (en) * 2015-02-03 2016-08-04 L'oreal Apparatus and method for skin treatment using continuous light

Also Published As

Publication number Publication date
GB202100486D0 (en) 2021-03-03
AU2019301569A1 (en) 2021-02-04
GB2587755A8 (en) 2021-05-19
WO2020010388A1 (en) 2020-01-16

Similar Documents

Publication Publication Date Title
WO2016145830A1 (en) Image processing method, terminal and computer storage medium
US10744403B2 (en) Method and apparatus for adjusting game scene
MX2020005138A (en) Strategic treatment of pressure ulcer using sub-epidermal moisture values.
CN111564192B (en) Control method of neck massager, neck massager and server
EP3089403A3 (en) Control method and control device for smart home device
WO2012170586A3 (en) Sleep management method and apparatus for a wellness application using data from a data-capable band
US20190018444A1 (en) Wearable apparatus and method for controlling vr apparatus
CN110579978B (en) Method and device for adjusting household appliance and storage medium
Valizadeh et al. Evaluation of safety and efficacy of 980-nm diode laser-assisted lipolysis versus traditional liposuction for submental rejuvenation: a randomized clinical trial
AU2013344818A1 (en) A device, system, method, computer program and data signal for the control of a transdermal delivery device
US20150164543A1 (en) Method for operating in a system for repetitive local puncturing of skin and system
GB2587755A (en) A method and apparatus for user-controlled or practitioner-prescribed transdermal, intradermal or transappendageal delivery of therapeutic, cosmetic or skin
CN103076954A (en) Method and device for adjusting display effect
WO2016205374A9 (en) Personalized nutritional and metabolic modification system
US10905222B2 (en) Personalization skin care product system, method and computer program product
US9715219B2 (en) Information processing apparatus, information processing method, and program
Kamolz et al. Tissue engineering for cutaneous wounds: an overview of current standards and possibilities
CN114377293A (en) Beauty instrument control method, equipment and storage medium
CN112785490B (en) Image processing method and device and electronic equipment
JP2021018496A (en) Robot body care system, robot body care method and robot body care program
CN107073256A (en) Portable remote controlled equipment for carrying out wrinkle treatment by amplitude-modulated current
KR20230027129A (en) Massage apparatus for having scalp massage function and operating method thereof
CN108499101A (en) A kind of games system based on physical examination data information
WO2019062601A1 (en) Video playback method, device and apparatus for massager
CN112932955A (en) Moxibustion control method, moxibustion control system and readable storage medium

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)